Still looking for a serialization solution? Implementing a mandated system may seem like drudgery. In this case study, you will learn how one contract packaging company took a different mindset and embraced the benefits of track and trace capability.
Counterfeit medicines are now a worldwide problem. According to some estimates, more than 10 percent of all drugs in the global supply chain are counterfeit and, in some countries, much higher.
Reliability of the equipment, compact design and user-friendly software are key factors in manufacturers’ choice for track and trace solution.
What potential do companies see in serialization and falsification protection?
The T2811 Label Serialization Compact prints and inspects labels with serialized data in one integrated system.
Being the starting point in a Track & Trace packaging line, the T2810 provides integrated serialization and ERP connectivity to comply with regulatory requirements.
Compact, fully integrated system for marking and verification of pharmaceutical Track & Trace products.
The T2410 allows for quick changeover in a broad variety of product formats, as well as seamless upgrades to adapt to an ever evolving market.
The stages below illustrate an excellent starting point for planning your serialization program, but should not be considered all inclusive. As with any program, the emphasis is on the planning stages – planning is critical in the serialization space. Time is of the essence. No manufacturer can afford to commit to a pilot and discover that the system you’ve been working with doesn’t have the proper backup capability in case of a power outage, or any other unforeseen situation.
Using workflow based software solutions to guide scientists through various processes in low to high throughput screening campaigns.
This webinar explores use cases showing how machine learning and analytics can help overcome the challenges facing the biopharma industry through more confident data-driven decisions.
Striving to bring the way we acquire, share and gain insights from scientific data, through a community and the framework for standardization and linked data.
Very few new molecular entities in active clinical development are readily bioavailable, and when dosed at escalated levels, even these may not be sufficiently absorbed. Learn how spray-dried amorphous dispersion might help.
